Similar results were reported by Ghelli Luserna Di Rorà et al., demonstrating that doxorubicin activates the ATR/CHK1 pathway and induces G2/M cell cycle arrest in ALL cell lines [36]. The gene discussed is CHEK1; the disease is acute lymphoblastic leukemia.